Abstract |
Recent studies have noted specific expression of hepatocyte nuclear factor ( HNF) 1beta in ovarian clear-cell adenocarcinoma (CCA). In this study, we aimed to determine whether HNF-1beta can be a specific marker of CCA in both the ovary and the endometrium and to assess the pathological significance of HNF-1beta expression in CCAs. We examined HNF-1beta expression immunohistochemically in 186 ovarian carcinomas, including 40 CCAs; 33 endometrial carcinomas, including 5 CCAs; 22 endometria at different stages of the menstrual cycle (5 in the proliferative, 12 in the secretory, and 5 in the menstrual phases); and 7 gestational endometria. The incidence of HNF-1beta immunoreactivity differed significantly between CCAs and other histology in both the ovary (100% in the former versus 2% in the latter) and the endometrium (100% in the former versus 0% in the latter) (P < .0001 each). In nonneoplastic endometrium, 25% or more immunoreactive cells were confined to the mid-to-late secretory phase of the menstrual cycle and gestational endometrium. HNF-1beta would be an excellent marker for distinguishing CCAs from other lesions in both the ovary and the endometrium. HNF-1beta expression seems to be associated with physiopathological cytoplasmic glycogen accumulation in these organs.
|
Authors | Sohei Yamamoto, Hitoshi Tsuda, Shinsuke Aida, Hideyuki Shimazaki, Seiichi Tamai, Osamu Matsubara |
Journal | Human pathology
(Hum Pathol)
Vol. 38
Issue 7
Pg. 1074-1080
(Jul 2007)
ISSN: 0046-8177 [Print] United States |
PMID | 17442376
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Hepatocyte Nuclear Factor 1-beta
|
Topics |
- Adenocarcinoma, Clear Cell
(metabolism)
- Endometrial Neoplasms
(metabolism)
- Endometrium
(metabolism)
- Female
- Hepatocyte Nuclear Factor 1-beta
(metabolism)
- Humans
- Immunohistochemistry
- Ovarian Neoplasms
(metabolism)
|